Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 11%
Buy 44%
Hold 44%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is well positioned to continue its positive momentum in the home healthcare market, with a strong focus on building preferred payor relationships and expanding into new markets through acquisitions. With its proven track record of delivering high-quality care and a growing demand for in-home services, Aveanna is set to see strong growth in both revenues and profitability in the coming years. Additionally, the company's strong compliance culture and focus on sustainability make it a long-term value play in the evolving healthcare landscape.

Bears say

Aveanna Healthcare Hldgs is exposed to major risks related to government reimbursement, nurse availability, and policy changes, which may affect its ability to maintain strong margins and growth as a home care provider. Additionally, its reliance on Medicaid reimbursement and dependence on acquisitions for growth may increase the company's vulnerability to regulatory and M&A risks. While the company has a strong value proposition and well-positioned for consolidation in the market, potential challenges in executing and integrating acquisitions may also impact its financial performance.

AVAH has been analyzed by 9 analysts, with a consensus rating of Buy. 11% of analysts recommend a Strong Buy, 44% recommend Buy, 44% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 9 analysts, AVAH has a Buy consensus rating as of May 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.